InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Berman Mark A.. Officer active across 1 company, notably Better Therapeutics, Inc.. Aggregated, 3 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €36k. History available since 5 April 2023. The latest transaction was disclosed on 18 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations